title: Questions remain regarding mandatory use of macrolides in community-acquired pneumonia.
authors.affiliation: Division of Infectious Disease, Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA. bwestley@lifespan.org.
authors.forename: Benjamin P
authors.initials: BP
authors.lastname: Westley
authors.affiliation: Division of Infectious Disease, Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.
authors.forename: Philip A
authors.initials: PA
authors.lastname: Chan
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D006801:Humans; D018942:Macrolides / Q000627:therapeutic use*; D018410:Pneumonia, Bacterial / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides